Streetbeat News

Price Targets

NAPA

JP Morgan analyst Andrea Teixeira maintains a Neutral rating on Duckhorn Portfolio (NYSE:NAPA) and lowers the price target from $18 to $17.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:34 pm

KRTX

JP Morgan analyst Cory Kasimov maintains an Overweight rating on Karuna Therapeutics (NASDAQ:KRTX) but lowers the price target from $260 to $250.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:33 pm

DG

JP Morgan analyst Matthew Boss maintains an Overweight rating on Dollar General (NYSE:DG) and lowers the price target from $238 to $187.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:32 pm

ASO

JP Morgan analyst Christopher Horvers maintains an Overweight rating on Academy Sports (NASDAQ:ASO) but lowers the price target from $70 to $61.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:31 pm

ITCI

JP Morgan analyst Jessica Fye maintains an Overweight rating on Intra-Cellular Therapies (NASDAQ:ITCI) and raises the price target from $58 to $62.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:29 pm

S

Morgan Stanley analyst Hamza Fodderwala maintains an Equal-Weight rating on SentinelOne (NYSE:S) and lowers the price target from $22 to $15.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:26 pm

HOOK

Morgan Stanley analyst Vikram Purohit maintains an Equal-Weight rating on HOOKIPA Pharma (NASDAQ:HOOK) and raises the price target from $2 to $2.25.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:26 pm

DG

Argus Research analyst Chris Graja maintains a Buy rating on Dollar General (NYSE:DG) but lowers the price target from $250 to $235.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:22 pm

PACB

Canaccord Genuity analyst Kyle Mikson maintains a Buy rating on Pacific Biosciences (NASDAQ:PACB) and raises the price target from $14 to $17.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:22 pm

IMGN

Canaccord Genuity analyst John Newman maintains a Buy rating on Immunogen (NASDAQ: IMGN) and raises the price target from $15 to $19.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:21 pm